AnalystsOlivia BrayerOlivia Brayer's Stock Forecasts
AnalystsOlivia Brayer
Sectors:
Industries:
Analyst Ranking
Top 45%
#2181 out of 4922 analysts
Average Return
+0.2%
Win Rate
42%23 out of 55
Risk vs Reward
Poor
Good
Olivia Brayer's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Vertex Pharmaceuticals IncVRTX | +41.12% | $358.40 | $505.78 | 2023-08-01 - 2024-08-01 | Strong Buy |
Vertex Pharmaceuticals IncVRTX | +36.06% | $343.96 | $468.00 | 2023-09-06 - 2024-09-06 | Strong Buy |
Vertex Pharmaceuticals IncVRTX | +35.77% | $343.00 | $465.70 | 2023-11-15 - 2024-11-15 | Strong Buy |
Vertex Pharmaceuticals IncVRTX | +35.61% | $325.30 | $441.13 | 2023-05-29 - 2024-05-29 | Strong Buy |
Vertex Pharmaceuticals IncVRTX | +35.07% | $347.00 | $468.71 | 2023-06-22 - 2024-06-21 | Strong Buy |
Olivia Brayer Analyst Color
Get additional color on Olivia Brayer's coverage of popular stocks
Olivia Brayer's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Verona Pharma PLCVRNA | 1 | Strong Buy | $100.00 | +6.59% | Maintains | 19 days ago |
United Therapeutics CorpUTHR | 1 | Strong Buy | $405.00 | +42.47% | Initiates Coverage On | a month ago |
Vanda Pharmaceuticals IncVNDA | 1 | Strong Buy | $13.00 | +171.97% | Assumes | 2 months ago |
Biomarin Pharmaceutical IncBMRN | 14 | Strong Buy | $90.00 | +63.13% | Reiterates | 4 months ago |
Vertex Pharmaceuticals IncVRTX | 22 | Strong Buy | $480.00 | +8.77% | Reiterates | 5 months ago |
Bristol Myers Squibb CoBMY | 9 | Hold | $55.00 | +18.66% | Maintains | 5 months ago |
Gilead Sciences IncGILD | 10 | Hold | $80.00 | -27.71% | Reiterates | 7 months ago |
Regeneron Pharmaceuticals IncREGN | 8 | Hold | $1,015.00 | +94.82% | Reiterates | 8 months ago |
Amgen IncAMGN | 2 | Strong Buy | $405.00 | +46.14% | Reiterates | 8 months ago |
Alnylam Pharmaceuticals IncALNY | 19 | Hold | $220.00 | -31.85% | Reiterates | 9 months ago |
Aurinia Pharmaceuticals IncAUPH | 5 | Strong Buy | $10.00 | +15.74% | Reiterates | 9 months ago |
Mannkind CorpMNKD | 3 | Strong Buy | $6.50 | N/A | Reiterates | a year ago |
Crispr Therapeutics AgCRSP | 1 | Strong Buy | $72.00 | N/A | Initiates Coverage On | 2 years ago |
Lenz Therapeutics IncLENZ | 2 | Hold | $3.00 | N/A | Downgrades | 2 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.